A major part of our business strategy is to form early stage collaborations, alliances and partnerships to support development and commercialization of our product pipeline.  We seek strong partners with expertise and resources that complement our capabilities and commitment for developing novel therapies for unmet medical needs in oncology orphan indications.  We intend to stay innovative and capital efficient to increase therapeutic assets value for our partners and investors.

If you are interested in partnering with us, please contact us: